Decision of the EEA Joint Committee No 301/2015 of 11 December 2015 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2017/1812]
Date: 2015-12-11
Institutions: EEA Joint Committee
Subjects: European Economic Area, chemical product, food hygiene, market approval, microorganism, plant health control, plant health product, preservative, revision of an agreement




L_2017263EN.01001101.xml










12.10.2017   


EN


Official Journal of the European Union


L 263/11








            DECISION OF THE EEA JOINT COMMITTEE
         
No 301/2015
of 11 December 2015
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2017/1812]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2015/1726 of 28 September 2015 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products for product-type 13 (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2015/1727 of 28 September 2015 approving 5-Chloro-2-(4-chlorophenoxy)phenol as an existing active substance for use in biocidal products for product-types 1, 2 and 4 (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2015/1728 of 28 September 2015 approving IPBC as an existing active substance for use in biocidal products for product-type 13 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2015/1729 of 28 September 2015 approving potassium sorbate as an existing active substance for use in biocidal products for product-type 8 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) 2015/1730 of 28 September 2015 approving hydrogen peroxide as an existing active substance for use in biocidal products for product-types 1, 2, 3, 4, 5 and 6 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) 2015/1731 of 28 September 2015 approving medetomidine as an active substance for use in biocidal products for product-type 21 (6) is to be incorporated into the EEA Agreement.












(7)


Commission Implementing Decision (EU) 2015/1736 of 28 September 2015 not approving triflumuron as an existing active substance for use in biocidal products for product-type 18 (7) is to be incorporated into the EEA Agreement.












(8)


Commission Implementing Decision (EU) 2015/1737 of 28 September 2015 postponing the expiry date of approval of bromadiolone, chlorophacinone and coumatetralyl for use in biocidal products for product-type 14 (8) is to be incorporated into the EEA Agreement.












(9)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
The following points are inserted after point 12nng (Commission Implementing Regulation (EU) 2015/1610) of Chapter XV of Annex II to the EEA Agreement:






‘12nnh.



32015 R 1726: Commission Implementing Regulation (EU) 2015/1726 of 28 September 2015 approving 2-methylisothiazol-3(2H)-one as an existing active substance for use in biocidal products for product-type 13 (OJ L 252, 29.9.2015, p. 14).










12nni.



32015 R 1727: Commission Implementing Regulation (EU) 2015/1727 of 28 September 2015 approving 5-Chloro-2-(4-chlorophenoxy)phenol as an existing active substance for use in biocidal products for product-types 1, 2 and 4 (OJ L 252, 29.9.2015, p. 17).










12nnj.



32015 R 1728: Commission Implementing Regulation (EU) 2015/1728 of 28 September 2015 approving IPBC as an existing active substance for use in biocidal products for product-type 13 (OJ L 252, 29.9.2015, p. 21).










12nnk.



32015 R 1729: Commission Implementing Regulation (EU) 2015/1729 of 28 September 2015 approving potassium sorbate as an existing active substance for use in biocidal products for product-type 8 (OJ L 252, 29.9.2015, p. 24).










12nnl.



32015 R 1730: Commission Implementing Regulation (EU) 2015/1730 of 28 September 2015 approving hydrogen peroxide as an existing active substance for use in biocidal products for product-types 1, 2, 3, 4, 5 and 6 (OJ L 252, 29.9.2015, p. 27).










12nnm.



32015 R 1731: Commission Implementing Regulation (EU) 2015/1731 of 28 September 2015 approving medetomidine as an active substance for use in biocidal products for product-type 21 (OJ L 252, 29.9.2015, p. 33).










12nnn.



32015 D 1736: Commission Implementing Decision (EU) 2015/1736 of 28 September 2015 not approving triflumuron as an existing active substance for use in biocidal products for product-type 18 (OJ L 252, 29.9.2015, p. 56).










12nno.



32015 D 1737: Commission Implementing Decision (EU) 2015/1737 of 28 September 2015 postponing the expiry date of approval of bromadiolone, chlorophacinone and coumatetralyl for use in biocidal products for product-type 14 (OJ L 252, 29.9.2015, p. 58).’






Article 2
The texts of Implementing Regulations (EU) 2015/1726, (EU) No 2015/1727, (EU) 2015/1728, (EU) 2015/1729, (EU) 2015/1730, (EU) 2015/1731 and of Implementing Decisions (EU) 2015/1736 and (EU) 2015/1737 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 12 December 2015, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 11 December 2015.


For the EEA Joint Committee


The President

Oda SLETNES
            





(1)  
            OJ L 252, 29.9.2015, p. 14.

(2)  
            OJ L 252, 29.9.2015, p. 17.

(3)  
            OJ L 252, 29.9.2015, p. 21.

(4)  
            OJ L 252, 29.9.2015, p. 24.

(5)  
            OJ L 252, 29.9.2015, p. 27.

(6)  
            OJ L 252, 29.9.2015, p. 33.

(7)  
            OJ L 252, 29.9.2015, p. 56.

(8)  
            OJ L 252, 29.9.2015, p. 58.

(*1)  No constitutional requirements indicated.